Cornell's newest interdisciplinary EEG lab could help faculty make breakthroughs in fields ranging from psychology to neurology to artificial intelligence.
Health information technology systems promised increased efficiency and reduced costs, but new ILR School-led research suggests these benefits have been elusive.
An FDA-approved drug used in humans has been found to inhibit the growth of oral squamous cell carcinomas in dogs - with one dog’s tumor nearly disappearing in a matter of weeks.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
A new method developed at Cornell provides tools and methodologies to compress hundreds of terabytes of genomic data to gigabytes, once again enabling researchers to store datasets in local computers.
A group of 34 earned their short white coats as the newest class in Weill Cornell Medicine’s Master of Science in Health Sciences for Physician Assistants program.
The resulting atlas advances basic research on the biology of the pancreas and could lead to new treatment strategies for diabetes and other pancreatic diseases.
New Cornell research shows that individuals of East Asian ancestry have greater risk of elevated iron stores than people of Northern European ancestry, putting them at higher risk of chronic conditions such as heart disease, Type 2 diabetes, liver disease and cancer.
Women who go on to develop postpartum depression may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy.